Table 1.
Demographic and clinical details of study subjects.
| Characteristic | Number (%) | ||
|---|---|---|---|
| Participants | 15 | ||
| A. PTB | |||
| Mean age (range, in years) | 30 (19–50) | ||
| Sex | Male | 10 (67) | |
| Female | 5 (33) | ||
| BCG vaccinated | 11 (73) | ||
| Nutritional deficiency | 5 (33) | ||
| Random blood sugar (range, in mg/dL) | 80–120 | ||
| H/o TB in family | 9 (60) | ||
| Close contact to TB patient | 11 (73) | ||
| Clinical symptoms | Cough | 15 (100) | |
| Fever | 15 (100) | ||
| Night sweats | 15 (100) | ||
| Weight loss | 15 (100) | ||
| Loss of appetite | 15 (100) | ||
| Hemoptysis | 6 (40) | ||
| Chest X-ray | Opacity | 4 (27) | |
| Opacity with cavitary lesion | 8 (53) | ||
| B. NHS | 17 | ||
| Mean age (range) | 32 (18–58) | ||
| Sex | Male | 11 (65) | |
| Female | 6 (35) | ||
| BCG vaccinated | 17 (100) | ||
| Random blood sugar range | 80–127 | ||
| H/o TB in family | 0 | ||
| QFT positives | 7 (41) | ||
PTB, pulmonary tuberculosis patients; NHS, normal healthy subjects; BCG, Bacillus Calmette–Guérin; H/o TB, history of tuberculosis; QFT, quantiferon; mg/dL, milligram/decilitre.